Feasibility of Remote Activity Assessment and PRO Collection Among Transgender Cancer Survivors
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- Cedars-Sinai Medical Center
- Study ID
- NCT05391217
- Status
- Recruiting
Conditions
- Chronic Disease
- Neoplasms
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Remote assessment of patient reported outcomes and daily activity — OTHERElectronic patient-reported outcomes (NIH PROMIS) will be collected and combined with remotely monitored physical activity, heart rate, and sleep, as measured with a Fitbit (Sense).
Study Details
Prospective observational feasibility study to evaluate the role of wearable activity monitors to determine the feasibility and acceptability of remote monitoring using wearable technology and PROs to monitor fatigue and physical function in transgender cancer patients and survivors.
Key Dates
- Start date
- Feb 1, 2023
- Status verified
- Aug 2024
- Primary completion
- Jul 1, 2025
- Completion
- Jul 1, 2025
Study Design
- Enrollment
- 20 participants (estimated)
Arms
- Arm: Transgender people with history of cancerSelf-reported cancer history and/or treatment for cancer within the last 5 years.
- Arm: Transgender people without history of cancerPeople living with other chronic conditions
Primary Outcome Measure
Feasibility of Remote Activity Assessment and PRO Collection [ Time Frame: 2 weeks ]
Central Contacts
- Gillian Gresham310-423-3341
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Cedars-Sinai Medical Center | Los Angeles | California | 90048 | Robert Haile, DrPH (SUB_INVESTIGATOR) Zulfikarali Surani (SUB_INVESTIGATOR) |
Find similar trials in Los Angeles, CA
By research site
Related Studies
- Novel Serum Markers for Monitoring Response to Anti-Cancer TherapyRecruiting · Stanford University · Stanford, California
- Collection of Tissue Samples for Cancer ResearchRecruiting · National Cancer Institute (NCI) · Sacramento, California
- Registry Study for Radiation Therapy OutcomesRecruiting · Proton Collaborative Group · Scottsdale, Arizona
- Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T CellsPHASE2/PHASE3 · Recruiting · Celgene · Birmingham, Alabama